Just as the Centers for Medicare and Medicaid Services finally releases a beta version of the VA’s VistA-Office electronic health record technology for small offices, a complication lurks on the horizon: name confusion.
Just as the Centers for Medicare and Medicaid Services finally releases a beta version of the VA's VistA-Office electronic health record technology for small offices, a complication lurks on the horizon: name confusion.
In July of this year, software giant Microsoft announced the name of its new Windows operating system: Vista.
"The timing of this is terrible. Microsoft released its name Vista just as CMS is getting the word out that they're offering VistA-Office to medical practices," said Barbara Boykin, chair of VistA Software Alliance, a nonprofit trade group charged with the development, installation, and maintenance of VistA-Office.
A Google search suggests that the trademark "Vista" is already owned by a custom software application and service provider based in Redmond, WA, named Vista.
John Wall, CEO of that company, was quoted July 23 in the Seattle Times as saying he was "considering all options" for a potential lawsuit against Microsoft.
There's more. The name of the software created for human genome research at the Lawrence Berkeley National Energy Research Scientific Computing Center is VISTA.
The Microsoft announcement just as the CMS was about to release VistA-Office prompted a loud outcry from healthcare.
"It's confusing to the doctors, it's distracting from a noble effort by CMS, and I think it's shameful that Microsoft would do this," Boykin said.
VistA-Office is based on electronic health record software developed by the Department of Veterans Affairs in the 1980s and renamed Veterans Health Information System and Technology Architecture (VistA) in 1996. VistA provides electronic records for millions of veterans in 163 hospitals, 135 nursing homes, and 850 clinics.
Other organizations have based their software on the VA's VistA, including the Pacific Telehealth and Technology Hui in Hawaii (backed by the VA and the Defense Department), and WorldVistA, a nonprofit organization founded in 2002 to promote the use of the open source VistA software.
Neither the VistA Software Alliance nor WorldVistA has a legal remedy available, since neither owns the trademark. The name "VistA" belongs to the VA, according to Boykin. It is unclear at this time whether the VA will pursue the matter through legal channels.
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.